Cargando…

Transforming growth factor-β1 and TGF-β2 act synergistically in the fibrotic pathway in oral submucous fibrosis: An immunohistochemical observation

BACKGROUND AND OBJECTIVES: Oral Submucous Fibrosis (OSF) is a potentially malignant oral disorder which leads to fibrosis of the oral mucosa and has a high rate of malignant transformation. The consumption of various forms of areca nut is causatively linked to the condition. The constituents of arec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamath, Venkatesh Viswanath, Krishnamurthy, Shruti, Satelur, Krishnanand P., Rajkumar, Komali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477373/ https://www.ncbi.nlm.nih.gov/pubmed/26157288 http://dx.doi.org/10.4103/0971-5851.158842

Ejemplares similares

Amelogenin in odontogenic cysts and tumors: An immunohistochemical study
por: Anigol, Praveen, et al.
Publicado: (2014)

Spindle cell variant of ameloblastic carcinoma arising from an unicystic amelobastoma: Report of a rare case
por: Kamath, Venkatesh V., et al.
Publicado: (2012)

Sexual dimorphism in tooth morphometrics: An evaluation of the parameters
por: Banerjee, Abhishek, et al.
Publicado: (2016)

Biochemical markers in oral submucous fibrosis: A review and update
por: Kamath, V V, et al.
Publicado: (2013)

Oral Lichenoid Lesions - A Review and Update
por: Kamath, Venkatesh Vishwanath, et al.
Publicado: (2015)

Expression of transforming growth factor β and its correlation with lipodystrophy in oral submucous fibrosis: An immunohistochemical study
por: Kale, Alka D., et al.
Publicado: (2013)

Expression of β-catenin in oral leukoplakia and oral submucous fibrosis: An immunohistochemical study
por: Chowdhury, Pritha, et al.
Publicado: (2021)

Expression of cyclooxygenase 2 in oral submucous fibrosis: An immunohistochemical pilot study
por: Rangaswamy, Shruthi, et al.
Publicado: (2019)

TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases
por: Pardali, Evangelia, et al.
Publicado: (2017)

Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease
por: Wang, Qingjian, et al.
Publicado: (2011)

Immunohistochemical Analysis of Vimentin in Oral Submucous Fibrosis
por: Nayak, Meghanand T., et al.
Publicado: (2013)

Expression of transforming growth factor-β in oral submucous fibrosis: A systematic review
por: Bansal, Shivani P., et al.
Publicado: (2023)

Activation of TGF-β Pathway by Areca Nut Constituents: A Possible Cause of Oral Submucous Fibrosis
por: Khan, Imran, et al.
Publicado: (2012)

Role of Areca Nut Induced TGF-β and Epithelial-Mesenchymal Interaction in the Pathogenesis of Oral Submucous Fibrosis
por: Pant, Ila, et al.
Publicado: (2015)

Comparison of Immunohistochemical Markers in Oral Submucous Fibrosis and Oral Submucous Fibrosis Transformed to Oral Squamous Cell Carcinoma—A Systematic Review and Meta-Analysis
por: Mohapatra, Diksha, et al.
Publicado: (2023)

TNFα activation and TGFβ blockage act synergistically for smooth muscle cell calcification in patients with venous thrombosis via TGFβ/ERK pathway
por: Wang, Penghui, et al.
Publicado: (2022)

NADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responses()
por: Jiang, Fan, et al.
Publicado: (2014)

Apilimod alters TGFβ signaling pathway and prevents cardiac fibrotic remodeling
por: Cinato, Mathieu, et al.
Publicado: (2021)

Research progress on drugs targeting the TGF-β signaling pathway in fibrotic diseases
por: Shi, Ning, et al.
Publicado: (2022)

GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition
por: Bestion, Eloïne, et al.
Publicado: (2020)

New Insights for Consummate Diagnosis and Management of Oral Submucous Fibrosis Using Reactive and Reparative Fibrotic Parameter Derived Algorithm
por: Ramadoss, Ramya, et al.
Publicado: (2021)

Senescent epithelial cells remodel the microenvironment for the progression of oral submucous fibrosis through secreting TGF-β1
por: Wang, Zijia, et al.
Publicado: (2023)

Interplay of Transforming Growth Factor-Beta 1 and 3 in the Pathogenesis of Oral Submucous Fibrosis and Its Malignant Transformation: An Immunohistochemical Study
por: Bansal, Shivani, et al.
Publicado: (2023)

Data on the effect of pro-fibrotic cytokine TGF-β on hepatic stellate cell autophagy
por: Thomes, Paul G., et al.
Publicado: (2016)

Diabetes induces fibrotic changes in the lung through the activation of TGF-β signaling pathways
por: Talakatta, Girish, et al.
Publicado: (2018)

A new FGFR inhibitor disrupts the TGF‐β1‐induced fibrotic process
por: Kim, Mi‐Hyoung, et al.
Publicado: (2019)

Resveratrol inhibits TGF-β1–induced fibrotic effects in human pterygium fibroblasts
por: Fan, Jianwu, et al.
Publicado: (2023)

The domino effect: Role of hypoxia in malignant transformation of oral submucous fibrosis
por: Chaudhary, Minal, et al.
Publicado: (2015)

Immunohistochemical analysis of syndecan-1 in leukoplakia and oral submucous fibrosis
por: Kamat, Sushant S., et al.
Publicado: (2013)

An immunohistochemical study of p53 expressions in oral submucous fibrosis
por: Manjunath, Sandesh, et al.
Publicado: (2019)

Qualitative expression of hypoxia-inducible factor-1α in malignant transformation of oral submucous fibrosis: An immunohistochemical study
por: Pereira, Treville, et al.
Publicado: (2020)

Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts
por: Shi, Xueke, et al.
Publicado: (2020)

Regulation of transforming growth factor-beta1 (TGF-β1)-induced pro-fibrotic activities by circadian clock gene BMAL1
por: Dong, Chunmin, et al.
Publicado: (2016)

Melatonin suppresses fibrotic responses induced by cigarette smoke via downregulation of TGF-β1
por: Shin, Na-Rae, et al.
Publicado: (2017)

The Effect of TGFβ1 in Adipocyte on Inflammatory and Fibrotic Markers at Different Stages of Adipocyte Differentiation
por: Maharjan, Babu Raja, et al.
Publicado: (2022)

Synergistic antitumor effects of a TGFβ inhibitor and cyclophosphamide
por: Chen, Xin, et al.
Publicado: (2014)

The Synergistic Cooperation between TGF-β and Hypoxia in Cancer and Fibrosis
por: Mallikarjuna, Pramod, et al.
Publicado: (2022)

Honokiol Acts as a Potent Anti-Fibrotic Agent in the Liver through Inhibition of TGF-β1/SMAD Signaling and Autophagy in Hepatic Stellate Cells
por: Kataoka, Seita, et al.
Publicado: (2021)

COVID-19: Immunohistochemical Analysis of TGF-β Signaling Pathways in Pulmonary Fibrosis
por: Vaz de Paula, Caroline Busatta, et al.
Publicado: (2021)

Immunohistochemical Expression of TGF-β1 in Kidneys of Cats with Chronic Kidney Disease
por: Uehara, Yuki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cphtknc6knmbbuvnlt9i8ccmuu